Good quality, competitives price.: ) Wuhan grand pharmaceutical group Co., Ltd. Founded in 1939 has a history of 70 years. It turned into a joint-stock company in 2002 wuhan grand pharmaceutical group Co., Ltd. Consists of 3-shared subsidiary companies, 10 workshops and one r & d center. It covers an area of 220, 000 square meters. Its registered capital is RMB 92.784 million, equal to USD 11.31512 million. Its annual sales volume is over USD 80 million and the export volume is about USD 24 millionThe main business of wuhan grand pharmaceutical group Co., Ltd. is the production and distribution of pharmaceutical ingredients, intermediates and preparations. It has an annual production capacity of more than 4000 tons in pharmaceutical ingredients, 4000 million units in solid pharmaceutical preparations (tablets and capsules), 200 million units in liquid pharmaceutical preparations (injection, infusion and eye drops). There are 7 sorts of pharmaceutical ingredients and intermediates in wuhan grand pharmaceutical group Co., Ltd., including antimicrobial drugs, antibechics, ophthalmic preparations, anticancer drugs, cardiovascular drugs, antipyretics and analgesics. The main products consist of analgin, chloramphenicol, metronidazole, enoxacin, enoxacin gluconate pirenoxin sodium, adrenline, noradrenaline bitartrate, xylometazoline hydrochloride, carbazochrome, tiopronin, aminphyrine and so on.